摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2-hydroxybenzyl)formamide | 86386-68-7

中文名称
——
中文别名
——
英文名称
N-(2-hydroxybenzyl)formamide
英文别名
N-[(2-hydroxyphenyl)methyl]formamide
N-(2-hydroxybenzyl)formamide化学式
CAS
86386-68-7
化学式
C8H9NO2
mdl
——
分子量
151.165
InChiKey
BIRZCWCEEIXUDY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    92-93 °C
  • 沸点:
    397.8±25.0 °C(Predicted)
  • 密度:
    1.191±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    49.3
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Sekiya,M. et al., Chemical and pharmaceutical bulletin, 1961, vol. 9, # 12, p. 945 - 948
    摘要:
    DOI:
  • 作为产物:
    描述:
    一氧化碳(氨基甲基)-苯酚1,5,7-三氮杂双环[4.4.0]癸-5-烯 作用下, 以 甲苯 为溶剂, 100.0 ℃ 、3.0 MPa 条件下, 反应 20.0h, 以83%的产率得到N-(2-hydroxybenzyl)formamide
    参考文献:
    名称:
    无金属一氧化碳(CO)的捕获和利用:胺的甲酰化
    摘要:
    1,5,7-三氮杂双环[4.4.0] dec-5-ene(TBD)对CO的捕获和利用是在没有过渡金属配合物的情况下进行的。TBD与CO的反应提供了TBD-CO加合物,将其转化为甲酰化的TBD(TBD-CHO)。TBD-CO加合物可能包括基于NMR和IR分析的CO与带正电物质的相互作用。在存在胺的情况下,CO从TBD-CO转移到胺中,以良好的收率生产甲酰化胺。基于理论计算,提出了涉及TBD-CO加合物的反应机理。
    DOI:
    10.1002/adsc.201900185
点击查看最新优质反应信息

文献信息

  • Cis-imidazolines
    申请人:——
    公开号:US20040259884A1
    公开(公告)日:2004-12-23
    The present invention provides compounds according to formula I 1 having the designations provided herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity.
    本发明提供了根据式I的化合物,具有此处提供的命名,以及其药学上可接受的盐和酯。这些化合物抑制MDM2蛋白与类p53肽的相互作用,并具有抗增殖活性。
  • [EN] 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES<br/>[FR] DERIVES DE 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE RENINE DANS LE TRAITEMENT DE L'HYPERTENSION, DE MALADIES CARDIOVASCULAIRES OU RENALES
    申请人:ACTELION PHARMACEUTICALS LTD
    公开号:WO2003093267A1
    公开(公告)日:2003-11-13
    The invention relates to novel 3,9-diazabicyclo[3.3.1]nonene derivatives of formula (I) and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors or renin.
    该发明涉及新型3,9-二氮杂双环[3.3.1]壬烯生物(I)及相关化合物,以及它们作为药物组合物中活性成分的用途。该发明还涉及相关方面,包括制备这些化合物的过程、含有这些化合物中的一个或多个的药物组合物,尤其是它们作为肾素抑制剂的用途。
  • 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension,cardiovascular or renal diseases
    申请人:Bezencon Olivier
    公开号:US20050176700A1
    公开(公告)日:2005-08-11
    The invention relates to novel 3,9-diazabicyclo[3.3.1]nonene derivatives of formula (I) and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors or renin.
    本发明涉及式(I)的新型3,9-二氮杂双环[3.3.1]壬烯生物及其相关化合物,以及它们作为药物组分在制备药物组合物中的应用。本发明还涉及相关方面,包括制备这些化合物的过程、含有其中一个或多个这些化合物的药物组合物,尤其是它们作为肾素抑制剂的应用。
  • 7-ARYL-3, 9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES
    申请人:BEZENCON OLIVIER
    公开号:US20080312242A1
    公开(公告)日:2008-12-18
    The invention relates to novel 3,9-diazabicyclo[3.3.1]nonene derivatives of formula (I) and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors or renin.
    本发明涉及新型的3,9-二氮杂双环[3.3.1]壬烯生物,其化学式为(I),以及相关化合物,以其作为药物成分制备制药组合物。本发明还涉及相关方面,包括制备该化合物的过程,含有其中一种或多种化合物的制药组合物,尤其是其作为肾素抑制剂的用途。
  • Silver halide color photographic material
    申请人:FUJI PHOTO FILM CO., LTD.
    公开号:EP0362870A2
    公开(公告)日:1990-04-11
    A silver halide color photographic material comprising a support having thereon at least one silver halide emulsion layer, wherein the silver halide color photographic material contains a compound represented by the following general formula (I): wherein A represents a group whose bond to (L)t-B is capable of being cleaved upon reaction with an oxidation product of a developing agent; L represents a group whose bond to B is capable of being cleaved after being cleaved from A; B represents a 5-membered, 6-membered or 7-membered. nitrogen-containing unsaturated heterocyclic group which has 2 to 6 carbon atoms, which is connected to A-(L) at the nitrogen atom, and which has a sulfonamido group and a development inhibitor group or a precursor thereof on the ring carbon atoms; t represents an integer of 0 to 2, and when ℓ represents 2, the two L's may be the same or different. The silver halide color photographic material has excellent sharpness and color reproducibility.
    一种卤化彩色感光材料,它包括在其上具有至少一个卤化乳剂层的支持物,其中卤化彩色感光材料含有由下通式(I)代表的化合物: 其中 A 代表其与 (L)t-B 的键在与显影剂的氧化产物反应时能被裂解的基团;L 代表其与 B 的键在从 A 裂解后能被裂解的基团;B 代表 5 元、6 元或 7 元的含氮不饱和杂环化合物。t代表0至2的整数,当ℓ代表2时,两个L可以相同或不同。卤化彩色感光材料具有极佳的清晰度和色彩再现性。
查看更多